Qinghai Spring Medicinal Resources Technology Co., Ltd. Stock
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 CNY | +4.10% | -6.73% | -60.54% |
Sales 2022 | 160M 22.12M | Sales 2023 | 214M 29.53M | Capitalization | 4.54B 627M |
---|---|---|---|---|---|
Net income 2022 | -288M -39.77M | Net income 2023 | -268M -37.01M | EV / Sales 2022 | 44.1 x |
Net cash position 2022 | 164M 22.71M | Net cash position 2023 | 158M 21.77M | EV / Sales 2023 | 20.5 x |
P/E ratio 2022 |
-25.1
x | P/E ratio 2023 |
-16.8
x | Employees | 173 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.91% |
1 day | +4.10% | ||
1 week | -6.73% | ||
Current month | -32.82% | ||
1 month | -28.40% | ||
3 months | -47.68% | ||
6 months | -62.94% | ||
Current year | -60.54% |
Managers | Title | Age | Since |
---|---|---|---|
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Lin Wang
DFI | Director of Finance/CFO | 55 | 18-05-17 |
Tie Peng Yao
BRD | Director/Board Member | 71 | 15-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 20-06-03 |
Rong Xiao
BRD | Director/Board Member | 54 | - |
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 3.05 | +4.10% | 22,327,560 |
24-05-23 | 2.93 | -2.66% | 22,526,090 |
24-05-22 | 3.01 | +0.67% | 23,008,840 |
24-05-21 | 2.99 | -5.08% | 23,856,140 |
24-05-20 | 3.15 | -3.67% | 23,698,360 |
End-of-day quote Shanghai S.E., May 23, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.54% | 247M | |
+37.65% | 6.04B | |
-19.68% | 4.27B | |
+4.49% | 3.28B | |
-15.69% | 2.96B | |
-5.64% | 2.43B | |
+44.89% | 1.93B | |
-12.71% | 1.59B | |
-4.27% | 1.58B | |
-14.86% | 1.5B |
- Stock Market
- Equities
- 600381 Stock